Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1 Baseline patient characteristics

Published byCatherine Harrington Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 1 Baseline patient characteristics"— Presentation transcript:

1 Table 1 Baseline patient characteristics
From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

2 Table 2 Cycles of chemotherapy received by baseline WHO performance status and by chosen chemotherapy regimen From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

3 Table 3 Surgery From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

4 Fig. 4 Survival by tumour stage.
From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

5 Fig. 3 Forest plots. From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

6 Fig. 1 Overall survival. From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

7 Table 4 Site(s) of first relapse
From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

8 Fig. 2 Progression-free survival.
From: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial Eur J Cardiothorac Surg. 2004;26(1): doi: /j.ejcts Eur J Cardiothorac Surg | Elsevier B.V.

Download ppt "Table 1 Baseline patient characteristics"

Similar presentations

Fig. 4-1, p. 107. Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.
P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.
Fig. 11-1, p. 359. p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.
Table 6-1, p. 161. Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.
Fig.1 Complexity of the surgeries according to BAS. Histogram.

Fig.1 Complexity of the surgeries according to BAS. Histogram.
Volume 144, Issue 1, Pages (January 2017)

Volume 144, Issue 1, Pages (January 2017)
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Diagram of method C for bronchial closure

Fig. 1 Diagram of method C for bronchial closure
Fig. 1 Clinical model of coronary collateral flow

Fig. 1 Clinical model of coronary collateral flow
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.

Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.
Table 1 Comparison of perioperative patient characteristics by groups

Table 1 Comparison of perioperative patient characteristics by groups
Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.
Volume 64, Pages e1-e3 (January 2017)

Volume 64, Pages e1-e3 (January 2017)
Prognosis of younger patients in non-small cell lung cancer

Prognosis of younger patients in non-small cell lung cancer

Similar presentations

Ads by Google